GW Pharmaceuticals Provides Preliminary Fourth Quarter and Full-Year 2020 Net Product Sales Results and 2021 Program Milestones
Total preliminary net product sales of approximately $148 million for the fourth quarter and approximately $526 million for the full
Read more